ArticleIBRO neuroscience reports2026
Cardiovascular risk factors, aging, and incidence of dementia (CAIDE) risk score and its association with cognitive performance and volumetric brain measures in mild cognitive impairment.
Article in IBRO neuroscience reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Background: The Cardiovascular Risk Factors, Aging, and Dementia (CAIDE) composite score is a promising measure connecting vascular health to cognitive decline; However, its association with brain imaging findings remains underexplored. This study aimed to evaluate the predictive value of the associations between CAIDE and structural brain measures in individuals with mild cognitive impairment (MCI). Methods: Participants (n = 226) aged 55-90 years with available CAIDE scores and white matter hyperintensity (WMH) measurements and a diagnosis of amnestic MCI were included. Regression models were used to evaluate the association between CAIDE score and neuropsychiatric and imaging findings. Results: Higher CAIDE scores were significantly correlated with lower MMSE scores (r = -0.22, p = 0.001) and higher CDR-SB (r = 0.34, p < 0.001) and ADAS-Cog 11 scores (r = 0.38, p < 0.001). CAIDE scores were significantly positively related to total cerebrum (β = 0.319), gray matter (β = 0.337), and hippocampal volumes (β = 0.250, all p < 0.001). ROC analysis demonstrated that total gray matter (AUC = 0.70) and total brain (AUC = 0.69) were more accurate predictors of dementia risk compared to WMH volume (AUC = 0.52). Conclusion: Higher CAIDE dementia risk scores were linked to poorer cognitive performance but showed limited association with WMH burden in individuals with MCI. Gray matter and hippocampal volumes were stronger correlates of dementia risk than WMH volume and CAIDE-related risk may be better captured by cortical and hippocampal structural changes rather than white matter disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.